The Hepatitis A vaccine of IIL, which is a wholly owned subsidiary of National Dairy Development Board (NDDB), vaccine represents a significant step forward in India's fight against Hepatitis A and is poised to make a substantial contribution to public health, a press release said.
The company in its growth strategy for 2030 said it has invested in Fujisan Asagiri Biomass that generates power from biogas derived from cow dung in Japan, and beginning its study.
